Definitive Contract 36C25723C0110
Award Date
9/18/23
Potential Completion Date
9/17/24
Potential Value
$878K
Federal Agency
Veterans Integrated Service Network 17
Awardee
RLS (USA) Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Temple, TX 76504, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Veterans Integrated Service Network 21 (VISN 21) of the U.S. Department of Veterans Affairs (VA). The contract is for the supply of radiopharmaceuticals and related supplies, with a ceiling value of $179,605.38 and a performance period through March 31, 2026. RLS (USA) Inc. is an established federal contractor, holding multiple Indefinite Delivery Vehicles (IDVs) with the VA and...
This is a $1,415,722.03 firm fixed price contract awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 7 to RLS USA Inc., a foreign-owned for-profit radiopharmacy company. The contract is for the provision of radiopharmaceuticals and related services to support nuclear medicine operations at VA medical facilities. RLS USA Inc. has received numerous federal contracts from VA and the Defense Health Agency to supply medical isotopes such...
This federal contract award to RLS (USA) Inc., a foreign-owned for-profit radiopharmacy company, is for the provision of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). The $833,285.36 firm fixed-price purchase order has a performance period ending on June 22, 2023. RLS (USA) Inc. is a small business that specializes in supplying critical molecular imaging products, including medical isotopes and radiopharmaceuticals, to support nuclear...
This is a $425,725.07 firm fixed-price delivery order contract awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The contract is for the supply of non-pet radiopharmaceuticals to support nuclear medicine diagnostic services at VA medical centers. It has a performance period from April 1, 2025 to March 31, 2026. The contract is not a set-aside. RLS (USA) Inc. is a small business that specializes in providing...
This federal contract award is to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, for the delivery of radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate. The contract, valued at $216,261.99, is a Delivery Order under a larger Indefinite Delivery Vehicle (IDV) with the Department of Veterans Affairs (VA) and the Defense Health Agency (DHA). RLS (USA) Inc. operates 31 radiopharmacy facilities across 18...
This is a firm fixed-price contract awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to RLS USA Inc., a foreign-owned, for-profit radiopharmacy, to provide various radiopharmaceuticals such as gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and other medical isotopes. The contract has a total potential value of $2,930,951.59 and includes a base year plus four one-year option periods, with deliveries to the VA Long Beach Healthcare System. The...
This federal contract award, identified as W81K0024P0074, was made by the Defense Health Agency (DHA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company. The $33,333.33 firm fixed-price purchase order contract is for the delivery of various radiopharmaceuticals, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military personnel at VA medical centers and military treatment facilities. RLS (USA) Inc. is a small...
The Defense Health Agency awarded a firm fixed-price purchase order contract to RLS USA Inc., a foreign-owned, for-profit radiopharmacy, to provide radiopharmaceuticals. The $200,000.00 contract has a completion date of September 30, 2023 and is designated as a total small business set-aside. RLS USA Inc. is a radiopharmacy that operates 31 facilities across 18 states, providing molecular imaging products and services to federal agencies including the Department of Veterans Affairs and the...
This firm-fixed-price delivery order contract was awarded to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, by the Department of Veterans Affairs (VA) Veterans Integrated Service Network (VISN) 17. The contract is for the provision of radiopharmaceuticals, including gallium-67, fluorodeoxyglucose F-18, thallium-201, technetium-99m, and Gallium-68 Dotatate, which are critical for nuclear medicine imaging procedures and diagnostic services provided to veterans and military...
This firm-fixed-price contract with a ceiling value of $852,160.60 was awarded by the Department of Veterans Affairs (VA) to RLS (USA) Inc., a foreign-owned, for-profit radiopharmacy company, to provide radiopharmaceuticals to the VA Long Beach Healthcare System in Long Beach, California. The contract has a base term of one year and four one-year option periods, with a total potential performance period through November 30, 2025. The contract was awarded under an unrestricted solicitation that...